Literature DB >> 4739107

Gynecomastia and impotence: complications of spironolactone therapy.

D J Greenblatt, J Koch-Weser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4739107

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  Drugs and male sexual function.

Authors: 
Journal:  Br Med J       Date:  1979-10-13

2.  Drugs and impaired male sexual function.

Authors:  J D Horowitz; A J Goble
Journal:  Drugs       Date:  1979-09       Impact factor: 9.546

3.  2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.

Authors:  Tzung-Dau Wang; Chern-En Chiang; Ting-Hsing Chao; Hao-Min Cheng; Yen-Wen Wu; Yih-Jer Wu; Yen-Hung Lin; Michael Yu-Chih Chen; Kwo-Chang Ueng; Wei-Ting Chang; Ying-Hsiang Lee; Yu-Chen Wang; Pao-Hsien Chu; Tzu-Fan Chao; Hsien-Li Kao; Charles Jia-Yin Hou; Tsung-Hsien Lin
Journal:  Acta Cardiol Sin       Date:  2022-05       Impact factor: 1.800

Review 4.  The emerging role of aldosterone/mineralocorticoid receptors in the pathogenesis of erectile dysfunction.

Authors:  Fei Wu; Yun Lin; Qingyong Liu
Journal:  Endocrine       Date:  2018-05-02       Impact factor: 3.633

5.  Contrasting effects of eplerenone and spironolactone on adrenal cell steroidogenesis.

Authors:  P Ye; T Yamashita; D M Pollock; H Sasano; W E Rainey
Journal:  Horm Metab Res       Date:  2008-09-25       Impact factor: 2.936

Review 6.  Effects of antihypertensive drugs on endocrine function.

Authors:  E P Brass
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

Review 7.  Gynecomastia and drugs: a critical evaluation of the literature.

Authors:  Frank Q Nuttall; Rohit S Warrier; Mary C Gannon
Journal:  Eur J Clin Pharmacol       Date:  2015-04-02       Impact factor: 2.953

Review 8.  Interfering with mineralocorticoid receptor activation: the past, present, and future.

Authors:  Anne M Dorrance
Journal:  F1000Prime Rep       Date:  2014-08-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.